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Abstract
Background—Improvements in care for inflammatory bowel diseases (IBD) could utilize the 
Chronic Care Model (CCM), an evidence-based approach that has improved patient outcomes and 
reduced costs in other illnesses. Specific aims include: (1) To explore patient perception of chronic 
illness care in a large IBD cohort, (2) To determine whether demographic factors, medication 
adherence, quality of life, disease type and activity were associated with perception of chronic 
illness care.
Methods—We randomly selected 1000 participants from the CCFA Partners internet cohort to 
receive the validated Patient Assessment of Chronic Illness Care (PACIC) instrument, which 
measures patient experience with specific aspects of care congruent with the CCM on a scale of 1–
5, with 5 being highest perception of care. We used descriptive and bivariate statistics to assess 
relationships.
Results—945 participants completed the PACIC [576 Crohn’s disease, 339 ulcerative colitis, 30 
indeterminate or other, 74% female, mean age 45 (SD=15.1), mean PACIC 2.4 (SD=0.93)]. 
Recent gastroenterologist visit, hospitalization, surgery and current pouch/ostomy were all 
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associated with significantly higher PACIC (p<0.05). PACIC correlated positively with quality of 
life (Pearson correlation=0.12, p=0.003) but not medication adherence or disease activity.
Conclusions—Reports of chronic illness care in this IBD cohort are in the same range as other 
illnesses. PACIC is positively associated with quality of life, so efforts to align care with the CCM 
may benefit this population. Subjects who had more sub-specialty interactions reported an 
increased perception of care, indicating the important role of direct patient contact.
Keywords
inflammatory bowel disease; chronic illness care; Patient Assessment of Chronic Illness Care 
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INTRODUCTION
Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis 
(UC), are chronic, relapsing illnesses affecting as many as 1.5 million individuals in the 
United States(1). IBD can negatively impact quality of life for patients(2) and carry a 
considerable cost burden for health care systems(3). Furthermore, there is a persisting gap in 
quality of care for IBD(4), as in many other illnesses. Ideally, improvements in care for IBD 
would improve patient outcomes and reduce costs while delivering high quality care across 
the United States.
The Chronic Care Model (CCM) is an evidence-based guide to quality improvement that has 
been studied in hundreds of settings since its development in 2001(5). The goal of the CCM 
is to establish proactive, planned care for chronic illnesses built upon productive interactions 
between active patients and proficient health care providers. The model provides specific 
recommendations for changes in the following six areas: health care organization, 
community resources, self-management support, delivery system design, decision support 
and clinical information systems. Implementation of CCM-based care has improved patient 
outcomes(6) and reduced costs(7) in diabetes, as well as many other diseases.
Based on findings in other illnesses, the CCM could be an effective framework for 
improving care for IBD. Additionally, one group has demonstrated decreased costs and 
health care utilization with a gastroenterologist-led shared care model for IBD that is 
congruent with some elements of the CCM(8). Before large-scale changes in health care 
delivery for IBD are implemented, however, appropriate tools for measuring CCM-based 
care need to be established. The Patient Assessment of Chronic Illness Care (PACIC) 
instrument is a short, validated survey that measures patient experience with specific actions 
and aspects of congruent with the CCM(9). To our knowledge, patient assessment of quality 
of care, as it pertains to the CCM, has not yet been evaluated in a large IBD population. The 
purpose of this study was (1) To explore patient perception of chronic illness care in a large, 
internet-based IBD cohort; (2) To determine whether demographic factors, medication 
adherence, quality of life, disease type and disease activity were associated with perception 
of chronic illness care.
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We performed a cross-sectional study of the relationship between patient assessment of 
chronic illness care and demographic factors, disease type and activity, medication 
adherence and quality of life, nested within a large, internet-based cohort study (CCFA 
Partners). CCFA Partners is an internet registry of IBD patients who complete twice-yearly 
online surveys about health history, disease management, and issues facing IBD 
patients(10). Inclusion criteria are self-reported IBD, age of 18 years or older and internet 
access. Since launching in 2011, CCFA Partners has over 12,000 participants.
Patient selection
Between February 4, 2012 and February 25, 2012, 1000 participants were randomly selected 
to receive the Patient Assessment of Chronic Illness Care (PACIC) instrument(9) in addition 
to the standard 6-month follow-up survey for the CCFA Partners study.
Instruments
The 6-month follow-up CCFA Partners survey was released to all eligible CCFA Partners 
participants and included questions on demographics, health care, smoking history, IBD 
characteristics, medications, family history, disease history, daily activity, quality of life and 
health status. Additional modules, including the PACIC, were released to varying numbers 
of participants. All instruments have been previously validated and are described below. All 
measures were reported for the time between baseline and follow up surveys (approximately 
6 months) unless otherwise specified by the instrument.
The Patient Assessment of Chronic Illness Care (PACIC) instrument consists of 20 
questions divided into 5 subscales (Patient Activation, Delivery System Design/Decision 
Support, Goal Setting, Problem Solving/Contextual Counseling, and Follow-up/
Coordination) which overlap all dimensions of the CCM that could be perceived by the 
patient(9). The PACIC measures the patient experience with actions or aspects of care that 
are consistent with the CCM within the past 6 months. It is scored by averaging the 
weighted values of all responses for the overall score or questions pertinent to each of the 
subscales. Results are expressed as a decimal value from 1–5, with 1 being the lowest 
perception of chronic illness care and 5 being the highest. The PACIC has been validated 
multiple times(11) and has been used in a variety of diseases. This instrument is the most 
appropriate instrument for measuring the patient experience of receiving integrated chronic 
care based on its psychometric characteristics, perceived applicability and relevance(12).
The short Crohn’s Disease Activity Index (sCDAI) was shown to be comparable to the 
original and widely-employed Crohn’s Disease Activity Index(13) in validity, reliability and 
responsiveness(14). It contains 15 questions and results are expressed as inactive disease 
(≤150), mild disease (151–199) and moderate to severe disease (≥200).
The Simple Clinical Colitis Activity Index (SCCAI) was validated in a longitudinal cohort 
study of patients undergoing colonoscopy, and was found to have excellent psychometric 
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validity and moderate to good performance of validity(15). A score of ≤2 is associated with 
remission(16) and a score of ≥5 defines a relapse of UC(17).
The Manitoba IBD Index (MIBDI) is a validated single-item indicator of IBD activity over 
an extended period of time (6 months for this study)(18). Responses were categorized into 
well or rarely active (a–b), occasionally or sometimes active (c–d) and often or constantly 
active (e–f).
The short IBD questionnaire (SIBDQ) is a validated, continuous measure of health-related 
quality of life that has been shown to correlate with disease activity in the IBD 
population(19). Scores range from 10 to 70 with 10 associated with low health-related 
quality of life and 70 being optimum.
The Morisky medication adherence scale (MMAS) consists of 8 questions regarding 
different aspects of medication adherence for various time periods(20). Each question is 
worth 1 point and results are expressed as the sum. Responses are categorized into low (1–
5), medium (6–7) and high (8) adherence.
Statistical analysis
All analyses were performed using SAS version 9.3 (Cary, NC). The population was 
characterized using descriptive statistics, including proportions, means and standard 
deviations, for overall IBD and stratified for CD and UC. Outcomes were compared using 
bivariate statistics, including the Student’s t test. The associations between PACIC scores 
and other continuous measures were described by Pearson correlation. Confidence intervals 
were 95% and p<0.05 was considered statistically significant. The study protocol was 




Of the 1000 participants selected to receive the PACIC survey, 979 (98%) started the survey 
and 945 (97% of those who started) completed the instrument [576 CD, 339 UC, 74% 
women, mean age 45 (SD=15.1)] (Table 1). Thirty participants reported indeterminate 
colitis or IBD unspecified and hereafter are included with UC. The majority of the 
respondents reported White race (94.9%). Nearly all were residents of the United States 
(96.9%). In general, respondents were well-educated, with 40.6% having completed a 
college degree and 32.2% with graduate-level education. A small percentage reported recent 
hospitalizations (9.0%), surgeries (4.2%) and current pouch (4.4%) or ostomy (6.4%).
Mean medication adherence score was 6.3 (SD=1.72) or moderate. A total of 213 
participants had a low adherence score (36.2%), 199 medium adherence (33.8%) and 176 
high adherence (29.9%). Mean quality of life as measured by the SIBDQ score was 51 
(SD=11.1), which is consistent with reported means for mild or inactive IBD(2, 10, 21, 22). 
Mean short Crohn’s Disease Activity Index was 52.1, indicating inactive disease. The mean 
Manitoba IBD index for CD was 3.65, indicating occasionally or sometimes active disease. 
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Mean UC disease activity as measured by the Simple Clinical Colitis Activity Index was 
3.3, or between relapse and remission. The mean Manitoba index for UC was 3.89, 
indicating occasionally or sometimes active disease.
PACIC: Overall and subscale scores
The mean PACIC score was 2.4 (SD = 0.93), which is within the range reported for other 
illnesses(23–26) (see Fig 1). The subscale domain of Patient Activation was significantly 
higher (p<0.0001) and the subscale domain of Follow-up/Coordination was significantly 
lower when compared across all other domains (p<0.0001).
PACIC: Association with patient and provider characteristics
The following characteristics were associated with a significantly higher PACIC score: 1 or 
more visit with a gastroenterology (GI) specialist in the past 6 months, 1 or more 
hospitalization or surgery in the past 6 months and current pouch or ostomy (p<0.05) (Table 
2). The following characteristics were not associated with a significant difference in PACIC 
score: demographic factors (including gender, age, education level), disease type (CD vs. 
UC) or duration, 1 or more visit with a primary care physician in the past 6 months and GI 
health care setting (university/academic vs. private practice). Recent GI visit significantly 
increased the Patient Activation (p=0.0003) and Problem Solving/Contextual Counseling 
(p=0.0008) subdomains. Recent hospitalization or surgery and current pouch or ostomy 
increased all subdomains.
PACIC: Association with disease activity, quality of life and medication adherence
Quality of life, as measured by SIBDQ, was found to have a modest but significant positive 
association with PACIC score (Pearson correlation = 0.119, p = 0.003). The associations 
between PACIC and disease activity as measured by a number of instruments were small 
and inconsistent (Table 3). For CD, PACIC was not associated with current disease activity, 
as measured by sCDAI and MIDBI. For UC, PACIC was significantly negatively associated 
with current disease measured by SCCAI (categorical p = 0.0107; continuous Pearson 
correlation = −0.144, p = 0.005); however, PACIC was not significantly associated with 
MIBDI for UC (p = 0.0726). Medication adherence did not correlate with PACIC score 
(p>0.05).
DISCUSSION
In this IBD population, overall PACIC scores were within the range reported for other 
illnesses. The Patient Activation subscale score was significantly higher and the Follow-Up/
Coordination subscale score was significantly lower than all others (p<0.0001) for the entire 
study population. Although the value of individual subscale scores is debatable due to high 
internal consistency(11), these findings suggest that the CCFA Partners internet-based 
cohort of individuals with IBD is highly active, motivated population. Data suggest that 
perhaps that the greatest deficits in care for IBD may be in the arena of continuity of care. 
Studies of diabetes(24, 27), mental illness(23), osteoarthritis(25) and other chronic 
illnesses(26) also found Follow-Up/Coordination to be the lowest subscale score, and hence 
targets for quality improvement work. The significant, positive association between PACIC 
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score and quality of life suggests that implementation of quality improvement in care for 
IBD based on the CCM could benefit this population; however, the correlation was weaker 
than expected (Pearson correlation = 0.12).
The association between sub-specialty care (such as visit with GI specialist, recent surgery 
or hospitalization or current pouch or ostomy) may result from increased opportunities for 
very sick patients to interface with their health care providers, resulting in increased 
perception of care. These findings may indicate an important role for direct patient contact 
in perception of quality of care, or could demonstrate a need to adjust for frequency of 
health care interactions in future studies using the PACIC instrument.
Associations between PACIC measurements of disease activity were inconsistent and only 
one was significant; thus, we fail to make any conclusive statements about the relationship 
between IBD activity and patient perception of care. Similarly, no relationship was found in 
a study of psychological support and disease activity with CD and UC patients(28). Disease 
duration was examined as a potential confounding factor, but no significant association was 
found between disease duration and PACIC score. Medication adherence was not found to 
be associated with PACIC, and this finding is consistent with studies in diabetes(29) and a 
study of many illnesses including diabetes, chronic pain, heart failure, asthma and coronary 
artery disease(26). While we found no statistically significant associations between 
demographic factors and PACIC scores, other reports show mixed associations with 
demographic factors. No association was found in a study of mental illnesses(23) and 
contradicting associations were found in different diabetes studies(9, 24), indicating that 
study population characteristics and specific health care settings may play an important role 
in patient perception of chronic illness care. It may not be possible to directly compare 
baseline PACIC scores in cross-sectional studies at different sites.
To our knowledge, this is the first reported instance of the PACIC instrument being used in 
an entirely self-administered, web-based setting. The high initiation (98%) and completion 
(97%) rates suggest no problems with the adaptation to a web-based format, completion of 
the survey and overall feasibility of an online version of the PACIC.
There are several strengths to this study of perception of chronic illness care in IBD. This 
study includes a large sample size, allowing for increased statistical power to describe 
associations between various clinical factors and perception of chronic illness care. 
Additionally, the population is quite diverse, as evidenced by the wide variability of 
demographic factors such as age, geographic location, education, health care setting and 
disease type, activity and duration. The limitations of this study include the cross-sectional 
design, which hinders our ability to draw causal conclusions regarding associations between 
PACIC and disease outcomes. PACIC scores may be more meaningful when used in a 
prospective study of PACIC scores at baseline with outcomes collected over time. Other 
weaknesses of this study include a lack of external generalizability, which is inherent to 
internet-mediated research, and the self-report IBD diagnoses within the CCFA Partners 
cohort.
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In conclusion, patient-reported experiences of chronic illness care in this IBD cohort are 
similar to reports for other illnesses. Perception of chronic illness care is positively, albeit 
modestly, associated with quality of life. Efforts to align care with the chronic care model 
may benefit this population.
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Table 1
Sample characteristics, n = 945
Characteristic Mean (SD) or percent
Demographics Age, years 44.9 (15.2)
Female 73.9%
United States resident 96.9%
Race/ethnicity
 White 94.9%
 African American <1%
 Asian 1.4%
 Native Hawaiian/Pacific Islander <1%
 American Indian/Alaskan Native <1%




 Less than 12th grade 1.1%
 12th grade 7.1%
 Some college 19.1%
 College graduate 40.6%
 Graduate school 32.2%
Current smoker 5.3%
Disease characteristics CD1 60.9%
UC2 35.9%
Indeterminate or other 3.2%
≥1 hospitalizations in the past 6 months 9.0%
≥1 bowel surgeries in the past 6 months 4.2%
Current Ileal or Koch pouch 4.4%
Current ostomy 6.4%
Health care setting Has PCP (seen at least once in past 6 months) 82.5%
Has GI specialist (seen at least once in past 6 months) 85.0%
GI specialist – University/academic setting 16.4%
GI specialist – Private practice 72.2%
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Characteristic Mean (SD) or percent
Mean scores Mean MMAS* 6.3 (1.72)
Mean SIBDQ+ 50.5 (11.1)
Mean Manitoba (CD) occasionally or sometimes active
Mean sCDAI$ 52.1











short Crohn’s Disease Activity Index,
#
Simple Clinical Colitis Activity Index
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Table 3
Association of mean Patient Assessment of Chronic Illness Care (PACIC) score and disease activity measured 
by 3 indices (sCDAI, SCCAI and Manitoba)
Mean PACIC (SD) p
sCDAI
n = 542
inactive, ≤150 2.42 (0.92) 0.159
mild disease, 151–199 2.83 (1.08)
moderate to severe disease, ≥200 2.63 (0.95)
SCCAI
n = 369
inactive, ≤2 2.46 (0.95) 0.011
mild disease, 2.1–4.9 2.33 (0.89)
moderate to severe disease, ≥5 2.12 (0.80)
Manitoba IBD Index – CD
n = 574
well or rarely active (a–b) 2.41 (0.95) 0.696
occasionally or sometimes active (c–d) 2.42 (0.93)
often or constantly active (e–f) 2.49 (0.92)
Manitoba IBD Index – UC
n = 369
well or rarely active (a–b) 2.20 (0.82) 0.073
occasionally or sometimes active (c–d) 2.29 (0.84)
often or constantly active (e–f) 2.46 (0.98)
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